Literature DB >> 7478522

A mutated p53 gene alters thyroid cell differentiation.

S Battista1, M L Martelli, M Fedele, G Chiappetta, F Trapasso, G De Vita, C Battaglia, M Santoro, G Viglietto, J A Fagin.   

Abstract

p53 is the gene most frequently found mutated in human neoplasias. In the majority of tumors, p53 mutations contribute to the progression towards stages of increasing malignancy with the appearance of an undifferentiated phenotype. Also in thyroid cancerogenesis, p53 mutations correlate with the loss of the differentiated phenotype. The results presented here, suggest a direct involvement of p53 in the molecular mechanisms regulating cellular differentiation in thyroid since a mutated p53 gene markedly affects the growth potential and differentiated functions of the rat thyroid cell line PC Cl 3. Blockage in the expression of the PAX-8 transcription factor seems to be a key event in the loss of thyroid differentiated functions induced by the mutated p53 gene. Thyroid cells carrying a mutated p53 gene did not form colonies in soft agar or tumors in athymic mice, suggesting that a mutation of the p53 gene is not sufficient for the induction of the malignant phenotype and probably a cooperation with other oncogenes is necessary to accomplish full malignancy. No effect on either growth or differentiation of thyroid cells was exerted either by overexpression of the wild-type p53 gene, or by the vector alone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478522

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas.

Authors:  K M La Perle; S M Jhiang; C C Capen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Molecular biology of thyroid cancer initiation.

Authors:  G Riesco-Eizaguirre; P Santisteban
Journal:  Clin Transl Oncol       Date:  2007-11       Impact factor: 3.405

3.  Mouse models of follicular and papillary thyroid cancer progression.

Authors:  Marika A Russo; Valeria G Antico Arciuch; Antonio Di Cristofano
Journal:  Front Endocrinol (Lausanne)       Date:  2012-01-10       Impact factor: 5.555

4.  Human thyroid cancer cells as a source of iso-genic, iso-phenotypic cell lines with or without functional p53.

Authors:  F S Wyllie; M F Haughton; J M Rowson; D Wynford-Thomas
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

Review 5.  Immune response in thyroid cancer: widening the boundaries.

Authors:  Laura Sterian Ward
Journal:  Scientifica (Cairo)       Date:  2014-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.